Phase 2 Pancreatic Cancer Trial, Recruiting NCT02598349 Sponsor: Proton Collaborative Group Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Phase 2 Pancreatic Cancer Trial, Recruiting

NCT02598349
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with pancreatic cancer (a specific type called adenocarcinoma) that cannot be removed by surgery, confirmed by a biopsy.
  • Your cancer is either too difficult to remove surgically, you have health reasons that make surgery unsafe, or you have chosen not to have surgery.
  • If you have a blockage in your bile duct, you may still be able to participate as long as a drainage tube has been placed before treatment begins.
  • If you are capable of becoming pregnant or fathering a child, you must be willing to use contraception during treatment and for at least 12 months afterward.
  • Your blood test results before starting treatment must meet certain requirements, meaning your blood cell counts, liver function, and kidney function are within acceptable ranges (confirm with trial site for specific values).

Who may not be able to join:

  • Your cancer has spread to other parts of the body beyond the pancreas.
  • You have already had surgery to remove part or all of the pancreatic tumor.
  • You have had another type of cancer in the past, unless it was a common form of skin cancer, a low-to-intermediate risk prostate cancer, or you have been cancer-free for at least 5 years.
  • You currently have an active infection that is not being treated.
  • You are pregnant, breastfeeding, or capable of having a child but unwilling to use contraception during treatment and for at least 12 months afterward.
  • You have previously received radiation therapy to your abdomen.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Proton Collaborative Group
Registry
ClinicalTrials.gov
Start date
1 April 2016
Est. completion
1 October 2039

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Overall survival at 12 months after radiation therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov